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Background: Publicly available information comparing performance across quality and costs has proliferated in
recent years, both about individual healthcare professionals and hospitals. This type of information is now
becoming increasingly available for physiotherapists with expertise in Parkinson’s disease (PD). Our study aimed to
explore the ability of people with Parkinson’s disease to recognise expertise, and to what extent respondents
selectively choose such expert physiotherapists.
Methods: We used claim data from the period 2009–2010 to select customers with PD who claimed
physiotherapy. A random sample of 500 eligible respondents received a paper-based survey. We used descriptive
statistics to compare the respondent characteristics, a qualitative programme to analyse the qualitative items, and
univariate and multivariate regression.
Results: Most respondents (89%) took their referring physician’s advice when selecting a physiotherapist, although
this advice rarely was supported with arguments. The remaining respondents (11%) searched for comparative
performance information about physiotherapists. Respondents who recognised the added value of PD expertise
among physiotherapists were 3.28 times as likely to search for comparative performance information as those who
did not understand. Respondents were willing to switch to an expert physiotherapist (68%), and this willingness
increased if they recognised the value of PD expertise (p < .001).
Conclusion: The participants were able to recognise certain aspects of expertise. Though they showed relatively
few signs of selectively choice behaviour for expert physiotherapists. Both respondents and referring professionals
need more understanding about the added value of an expert physiotherapist, to foster selective provider choice.
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The release of information in the public domain about
the performance of healthcare providers has become a
strategy for improving the quality of healthcare [1]. Pro-
viding such comparative performance information (CPI)
may empower and enable patients to identify and choose
high-quality providers [2,3]. While we have an increasing
understanding of motivating factors for selective pro-
vider choice regarding elective conditions [4-6], or pri-
mary care physicians [7] there is no knowledge available
about whether this evidence also applies to people with
a chronic disorder such as Parkinson’s disease (PD). Our* Correspondence: Nicole.Ketelaar@radboudumc.nl
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reproduction in any medium, provided the oraim is to explore whether people are aware of, and able
to recognise expertise, as an expression of quality of
care, in PD among physiotherapists.
There are an estimated 1.2 million people with Parkinson’s
disease (PwP) in Europe [8]. Physiotherapy is part of the
treatment for many PwP [9]. In the Netherlands and the
United Kingdom, 54–60% of all PwP receive physiotherapy
[10,11]. In the former, physiotherapy is mainly provided in
community-based settings, in provider-owned practices.
The reimbursement of the first 21 physiotherapy sessions,
on annual basis, depends on the consumers additional insur-
ance package. Though, for the treatment of PD there is an
unlimited reimbursement out of the basic insurance after
these twenty-one treatments. Dutch patients have free ac-
cess to physiotherapy since 2006 so they can self-refer to al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ise for selective provider choice [12].
More than 75% of the Dutch allied health professionals
report a lack of PD-specific expertise. More than half of
them were unfamiliar with the treatment options of other
professionals, and they had not participated in relevant edu-
cational programmes [9]. In response to this gap of know-
ledge, a Dutch multidisciplinary network, ParkinsonNet, was
developed and implemented to increase the PD expertise of
physiotherapists [13]. ParkinsonNet is a multifaceted inter-
vention that includes several elements (Table 1).
Launching of the sixty-fifth regional ParkinsonNet-
network in 2010, national coverage was achieved. Cur-
rently, about 2700 professionals are connected throughout
the Netherlands [14]. Although, physiotherapists can be
expert in PD without being connected to this multidiscip-
linary network, the term ‘expert physiotherapist’ is exclu-
sively used throughout this paper for physiotherapists who
are connected to ParkinsonNet. An expert physiotherapist
received additional training in treating PwP. Evidence
shows that specific treatment options provided by ex-
pert physiotherapists are more beneficial to patients
[15,16]. Also, expert physiotherapists show better guide-
line adherence scores compared to generically active phys-
iotherapists and their PwP volume is larger [9].
Awareness of referral options for other professional
disciplines [17] and knowledge and use of the Dutch PD
guideline [13] are necessary to attain expertise in PD.
The implementation of ParkinsonNet increased the num-
ber of PwP treated by each physiotherapist [18]. However,
approximately 70% of the PwP are still treated by a general
physiotherapist [18]. This raises the questions whether
PwP are aware of PD expertise in physiotherapy and
whether they understand its value, i.e. these are, apart
from free provider choice, two additional relevant condi-
tions for selectively choosing a provider.
This paper focuses on ability of PwP to recognise ex-
pertise in PD among physiotherapists, as a potential
indicator of selective provider choice. We consider this
in several ways: by seeking the perspective of PwP
about the PD expertise of their physiotherapist, by
ascertaining the descriptions of PD expertise from theTable 1 Five core elements of ParkinsonNet [14]
1 Delivering care according to evidence-based guidelines
2 Continuous education and training of therapists (including
physiotherapists, occupational therapists, and speech therapists)
3 Structured and preferred referral to ParkinsonNet therapists by
neurologists, enabling each therapist to attract a large volume of
patients to increase expertise
4 Encouraging communication and regional collaboration with
referring physicians
5 Promoting visibility of the available expertise for both patients and
professionalsperspective of PwP in a qualitative way, and whether phys-
iotherapists’ PD-related expertise influences the search for
CPI among PwP. In addition, we examine the role of refer-
ring physicians. We take into account factors that might
affect provider selection such as consumer characteristics
(e.g. age, education, and internet use), knowing where to
search for CPI, the willingness to switch, and respondents’
expectations regarding variation in quality of care.
Methods
Design and study population
Our paper-based survey focused on the selective pro-
vider choice for expert physiotherapists in a cohort of
people with PD. We selected PwP on the basis of claim
data in the period 2009–2010 of a Dutch healthcare in-
surance company that accounts for 20% of the Dutch in-
surance market. We approached eligible candidates,
that is, people who were registered as having PD in the
diagnosis–treatment combination (Dutch version of
diagnosis related groups) combined with an episode of
physiotherapy in the year prior to our survey. Only
consumers who received physiotherapy treatment for
PD were included because we wanted to focus on peo-
ples’ capacity to recognise physiotherapists’ PD expert-
ise. People who had had physiotherapy for PD for several
years were excluded; the decision-making process (delib-
erate or not) had to be recent to exclude recall bias. A
total of 886 patients met these eligibility criteria. We sent
surveys to 500 participants randomly selected from this
group. Due to privacy legalities, the insurance company
drew the sample. According to local regulations in the
Netherlands (Commission involving human subjects re-
search) (CMO) region Arnhem-Nijmegen) this study did
not need approval of the ethical review board.
Measures and data collection
The survey consisted of 37 items. The first items ascertained
the treatment with physiotherapy for PD in the past year to
satisfy our inclusion criteria. We used five items to oper-
ationalise the recognition of physiotherapists’ PD expertise.
Two items explored the level of awareness and the descrip-
tions of PD expertise from the perspective of the par-
ticipants: awareness of the existence of expert PD
physiotherapists (dichotomous variable), and partici-
pants were asked to estimate whether their physiother-
apist was an expert in PD. This latter item was answered
on a three-point scale: yes, no, or do not know. We com-
pared the participants’ views of physiotherapists’ expertise
on the basis of claim data with the ParkinsonNet data to
see if they correlated. The respondents answered an open-
ended question that dealt with their assessment of physio-
therapists’ expertise. We categorised the answers into
eight core themes based on a framework for patient cen-
teredness in PD [19] and quality of care domains as
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tion, Recognition of physiotherapist expertise in Parkinson
disease). We estimated the search for CPI by addressing
the last two aspects used to operationalise the recognition
of physiotherapists’ PD expertise: recognition of the added
value of PD expertise, and whether participants paid at-
tention to PD expertise among physiotherapists when they
selected a provider (all dichotomous variables).
Knowing where to look for CPI was a dichotomous
variable. Expectations of variation in the quality of care
between a generic physiotherapist and an expert physio-
therapist formed a categorical variable, determined on a
four-point scale: yes, large differences; yes, small differ-
ences; do not know; or no differences. The willingness
to switch to an expert physiotherapist was determined
on a five-point scale: most likely, likely, unlikely, most
unlikely, and do not know. We dichotomised this into
likely (most likely, likely) versus unlikely (most unlikely,
unlikely, do not know) because the distribution of this
variable was positively skewed.
We assessed the role of referring physicians with the
following questions: do referring physicians provide you
multiple choice options for physiotherapists about where
you could go to? Did your referring physicians give you
an advice to which provider you should go for the best
treatment? If so, is this advice accompanied by argu-
ments and by CPI, and do you take this advice? (All of
these are dichotomous variables).
We asked the participants which attributes they searched
for when choosing a physiotherapist, and for which of
these attributes referring providers supplied them with in-
formation. The attributes contain items about services and
quality of care. The first three items were available for PwP
at the time the survey was send out, we added items 4 and
5 because we expected that these items soon become avail-
able as well and/or these items were common items with
other (elective) conditions.
1. ParkinsonNet membership, e.g. practices connected
to this network.
2. Information regarding the added value of being
treated by an expert PD physiotherapist.
3. Distances to physiotherapy practices.
4. Physiotherapists with PD expertise.
5. Experiences of PwP who were treated by an expert
physiotherapist.
We also ascertained the demographics of the study par-
ticipants. We treated age as a continuous variable. The
variable of educational level was described as none/low,
average, or high. We used the stages defined by Hoehn
and Yahr [21] to describe the self-reported disease charac-
teristics. The Hoehn and Yahr (HY) stages range from no
PD signs in stage 0 to needing a wheelchair or beingbedridden in the most severe stage 5. Patients’ disease se-
verity was classed as mild (HY stages 0–1), moderate (HY
stages 2–3), or severe PD (HY stages 4–5).
The survey was field tested and optimised for ten pa-
tients and four PD researchers. The final survey was sent
by post, and a reminder was posted 2 weeks later. Data
were collected in October and November 2010.
Analysis
The survey contained four qualitative questions. The
filled-out paper-copy surveys were scanned and tran-
scribed into an electronic format, by means of an auto-
mated process (Teleform). We did not use a separate
programme for the qualitative analysis, such as Atlas.ti,
as it did not bring much benefit for the rather small
amount of qualitative data. Though we did apply the
principles of thematic analysis (conducted by NK and
MF), supported by the PD-specific framework for patient
centeredness [19] and a general framework for quality of
care [20]. Descriptive statistics were calculated for each
survey item and compared with respondent characteris-
tics. We explored the association between how patients
value PD expertise and the search for CPI (treated as a
dependent variable determined by ‘yes’ or ‘no’). We used
univariate logistic regression analysis to separately exam-
ine the associations between the independent variables
and the search for CPI. The independent variables were:
age, education, internet use, awareness of the existence of
expert PD physiotherapists, an understanding of the added
value of an expert PD physiotherapist, prior attention to
physiotherapists’ expertise, knowing where to search,
expected quality differences between generic physiothera-
pists and expert physiotherapists, willingness to switch,
and the provider options named by referring physicians.
Statistically significant variables (p < 0.05) were included
in the stepwise forward multivariate logistic regression
analysis. We calculated the outcomes separately for each
independent variable while controlling for the other vari-
ables in the model. We presented these outcomes with
odds ratios (ORs) and 95% confidence intervals (CIs). We
used SPSS 18.0 to carry out the analyses.
Results
Demographics
In total, 380 respondents completed the survey (gross
response rate = 76%), and 320 surveys were analysed (net
response rate = 64%). The 60 participants whose surveys
were excluded had not received physiotherapy for PD,
but for another medical condition. Table 2 presents the
background characteristics of the study population.
Quality of care for Parkinson’s disease
Sixty percent of the study population expected quality dif-
ferences in the care provided by generic physiotherapists
Table 2 Background characteristics of study population
General characteristics n %
Gender Male 147 56








Other situation 36 11
Internet use Yes 85 28
Specific Parkinson’s Disease characteristics
Diagnosis
Parkinson’s disease 292 95
Atypical parkinsonism 10 3
Unknown 4 2
Hoehn and Yahr stage (self-reported)
Mild (0–1) 83 30
Moderate (2–3) 127 41
Severe (4–5) 87 29
Use of physiotherapy in the past year Yes 320 100
Because of missing data in the background characteristics, not every score
accumulates to the total of 320.
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these variations would be large. A minority of participants
(5%) expected no quality differences, and the remaining
respondents (35%) said they did not know. Of those who
expected quality differences, 33% did not know what kind
of value an expert physiotherapist could add. In total,
about half the study population (51%) did not know the
added value of an expert physiotherapist. Participants who
expected to find quality differences were younger than
participants who did not expect quality differences (71 ±
10 years versus 74 ± 8 years, p = .009).
More than two-thirds of the respondents (68%) were
willing to switch to an expert physiotherapist if it turned
out that their current physiotherapist had no PD expert-
ise. The distance the participants were willing to travel
to see an expert physiotherapist was 5 km (interquartile
range: 2–11 km). Respondents who had previously heard
about expert physiotherapists were more willing to switch
(82% versus 54%, p < .001) and respondents expecting dif-
ferences in the quality of care were also more likely to
switch (87% versus 31%; p < .001).
Recognition of physiotherapist expertise in Parkinson disease
Most participants (74%) had already heard about expert
physiotherapists. Fewer participants (46%) said they hadpreviously paid attention to whether the physiotherapist
was an expert in PD before selecting a physiotherapist.
Participants who had previously heard about physiother-
apists with PD expertise had a higher educational level
than those who did not know about expert physiothera-
pists (p = .001). Awareness of expert physiotherapists
was also related to age. Participants who were aware of ex-
pert physiotherapists were younger than those who were
unaware (71 ± 10 years versus 76 ± 8 years, p = .001).
We asked those who had already heard about expert
physiotherapists whether they were treated by an expert
PD physiotherapist (n = 229). More than 70% asserted
they were treated by an expert, 12% stated that they were
not, and 17% said they did not know. A comparison of the
answers of our study population with ParkinsonNet data
showed that 28% of our respondents were being treated
by a ParkinsonNet-affiliated physiotherapist.
Participants reported various themes describing what
physiotherapists’ expertise and knowledge stands for.
Table 3 presents the core themes and the underlying de-
scriptions that the respondents gave. Thirty percent of
the respondents said that physiotherapists’ treatment,
exercises, and information express a degree of expertise.
The role of referring physicians
The respondents were referred by: neurologists (49%),
general practitioners (GPs; 18%), and specialist Parkinson’s
nurses (18%). Another 15% of the respondents saw a
physiotherapist on their own initiative. About half the par-
ticipants who received a referral were provided with add-
itional information regarding expert PD physiotherapists.
Only a minority of the respondents (25%) received mul-
tiple choice options for a physiotherapist. Although 85%
of the participants found it important to choose their own
physiotherapist, most (89%) of those with a physician re-
ferral took their physician’s advice when selecting a
physiotherapist.
The search for comparative performance information
Most respondents (89%) reported not having searched
for CPI when it became clear they needed physiotherapy.
Some respondents gave more than one reason for not
searching. The most important reason was not perceiv-
ing any need for more information (60%). Other reasons
were: no internet access at home (29%), not knowing
where to search (15%), not knowing how to search (9%),
lack of motivation (13%), not knowing how to look for
information (12%). A smaller group found that more in-
formation led to more doubt (7%), some felt that it was
too much responsibility (4%), and some had no time (3%).
Participants who searched for information (11%) wanted
to know about: practices connected to ParkinsonNet (n= 13,
4%), expert PD physiotherapists (n= 18, 6%), physiotherapist
practices close to home (n = 19, 6%), experiences of patients
Table 3 Themes related to the perceived expertise of physiotherapists from the patients’ perspective
n
Treatment and therapy 69
Treatment and exercises ‘Expertise is related to the good exercises I have to do at home’ (Woman,
82 years old)
‘Right exercises for posture and movement’ (Man, 76 years old)
Tailored information and communication 66
Information about the disease, (practical) advice, counselling, and
communication with physiotherapist
‘All arguments with the given instructions are correct’ (Man, 64 years old)
‘He tries to find matching exercises for me in person’ (Man, 70 years old)
‘She knows a lot of Parkinson Disease, I receive good answers to my Parkinson
Disease related questions’ (Woman, 74 years old)
Knowledge of Parkinson disease 34
Knowledge about and expertise in Parkinson disease symptoms.
Noticing changes of condition
‘He knows exactly what to do’ (Man, 78 years old)
‘He knows the Parkinson disease signs and tries the recommended treatment’
(Man, 57 years old)
‘She knows the limitations Parkinson disease imposes on me, and gives useful
suggestions’ (Woman, 82 years old)
‘Works with several patients who have Parkinson disease’ (Man, 60 years old)
Effectiveness 25
Improved condition, increased mobility, decreased freezing ‘I can to move better and my muscles are less stiff since the treatment’
(Woman, 82 years old)
‘My condition has improved since this treatment’ (Man, 75 years old)
Cooperation with caregivers 19
Need for interdisciplinary care. Working within a network with
allied healthcare providers
‘He works with the neurologist’ (Man, 73 years old)
‘He is involved in the Park fit studies’ (Man, 71 years old)
Emotional support, empathy, and respect 16
The patient receives interest and attention, is taken seriously,
patient’s disease is accepted and coped with
‘Shows great interest’ (Man, 74 years old)
‘Shows interest, takes me seriously’ (Woman, 77 years old)
‘Is very patient’ (Man, 88 years old)
Unable to define the expertise of the physiotherapist 4
Difficult to access the providers’ expertise ‘I do not know which exercises are the best for patients with Parkinson disease’
(Man, 61 years old)
Treatment evaluation 2
Providers ask questions about the treatment ‘Takes the time to evaluate the treatment process’ (Man, 70 years old)
Accessibility of healthcare 2
Treatment or physiotherapy at home ‘Treats me at home’ (Man, 70 years old)
Total 103
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(n = 7, 2%), and what added value physical treatment
from an expert physiotherapist can give a person with
PD (n = 11, 3%). Some declared they did not find the
information they would have like to have. Others
reported that the information was too general and not
trustworthy.
Univariate logistic regression analyses revealed that
several variables are associated with the search for CPI.
Respondents’ awareness of expert PD physiotherapists,
an understanding of the added value of an expert
physiotherapist, and the willingness to switch to anexpert PD physiotherapist were statistically significant,
as were consumer characteristics (age and internet use).
These variables were included in the multivariate regres-
sion analysis.
The stepwise multivariate logistic regression analysis
revealed that recognising of the added value of an expert
PD physiotherapist was the most important predictor
for the search for physiotherapists’ CPI (Table 4). The
likelihood of people who recognised the added value
searching for information was 3.28 times as great as
the likelihood for those who did not recognise (OR = 3.28
[95% CI 1.42–7.58]).
Table 4 Univariate and forward stepwise multivariate regression relationship of searching for comparative
performance information versus background characteristics, awareness, and understanding physiotherapists’ expertise
in Parkinson’s disease
Univariate analyses Multivariate analyses
OR [95% CI] P OR [95% CI] P
Age 0.96 [0.93–0.99] 0.02*
Educational level (low)†
Middle 1.49 [0.69–3.23] 0.32
High 0.73 [0.20–2.61] 0.62
No internet use 2.12 [1.02–4.39] 0.04*
Not aware of expert PD physiotherapists 3.76 [1.11–12.70] 0.03*
No recognition of added value of expert physiotherapist 3.29 [1.47–7.31] 0.01* 3.28 [1.42–7.58] 0.01*
No prior attention to physiotherapist expertise 0.57 [0.18–1.82] 0.34
Not knowing where to look for CPI 1.13 [0.30–4.16] 0.86
No quality differences between generic and expert physiotherapists†
Yes, large differences 1.41 [0.29–6.80] 0.67
Yes, small differences 0.91 [0.17–4.73] 0.92
Do not know 0.26 [0.04–1.56] 0.14
Not willing to switch 3.86 [0.89–16.78] 0.07
Received provider options from referring physician 1.79 [0.77–4.14] 0.17
The total number of respondents included in the analysis was 279.
*p < 0.05.
†Reference category.
CI, Confidence interval; CPI, comparative performance information; OR, odds ratio; PD, Parkinson’s Disease.
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The ultimate goal of releasing CPI about the quality of
expert physiotherapists is to improve quality of care for
people with PD. Consumers of health care have the
power to make a contribution to quality of care in com-
petitive health care system by selective provider choice.
This study shows that PwP identify aspects of expertise
that appeared to align with the IOM-framework for
quality of care, and mostly with patient centeredness.
Moreover, the majority of participants (74%) were aware
of expert and non-expert PD physiotherapists. Partici-
pants were able to describe what the PD-specific expert-
ise and knowledge of their physiotherapist means to
them. However, we found little evidence suggesting
that the influence on how patients value expertise
among physiotherapists influences the search for CPI
and selective provider choice. Recognition of the add-
itional value of a PD physiotherapist was a strong pre-
dictor of such a CPI search. Yet, about half the patients
(51%) had this understanding; therefore, this situation can
be improved. Our study shows that PwP hardly ever se-
lectively chose a physiotherapist with PD expertise.
Most took the physicians’ referral advice (89%), and
the influence of CPI in the decision-making process
was limited because only a minority searched for such
information (11%).In terms of the way forward, we first discuss the se-
lective referral behaviour of physicians. Currently, very
few physicians’ selective referrals to expert physiothera-
pists occur. Only half the participants were given add-
itional information regarding expert PD physiotherapists.
A King’s Fund publication [22] shows that most GPs in
the United Kingdom did not give information about their
referrals either. Knowing and recognising PD expertise are
necessary conditions for providers’ selective referrals.
Without these conditions, it is difficult to provide patients
with information. It is also important that referring physi-
cians (e.g. neurologists and GPs) proactively recall this
knowledge when they advise and refer patients to a
physiotherapist. Referring physicians should support con-
sumers choose selectively by discussing their referral op-
tions, so that the choice becomes a matter of shared
decision-making.
Second, we focus on the consumer’s selective choice
behaviour. Previous studies suggest that, although con-
sumers value quality information [23,24], the use of CPI
is limited [1,25,26] among different populations and for
a diversity of conditions. Our study confirms this dis-
crepancy. The respondents valued free provider choice as
important, but usually followed the referring provider’s
advice and did not use CPI to choose their physiotherap-
ist. Previous research shows that once people understand
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to the measures of quality performance [27]. Further
research should address in what way this discrepancy
can be countered, for example by improving the cir-
cumstances so that consumers’ intentions and their be-
haviour coincide.
Characteristics of expertise, as they were perceived
and expressed by PwP in their own words (Table 3), are
connected with the definition of patient-centred care for
PD [19]. Other quality criteria, like a large PwP volume,
having followed specific training in treating PD and a
connection to an expert network, which is important for
the members of ParkinsonNet, were less frequently
mentioned. We therefore conclude that the definition
of expertise among respondents was rather narrow.
The aspects that were less frequently mentioned by re-
spondents, might need more attention since recent evi-
dence shows that PwP allocated to multidisciplinary
PD care have better quality of life, better motor scores,
and less depression [28].
Moreover, at a time when cost control dominates the
health policy agenda, it is more urgent than ever to sup-
port consumers become a force for improving the qual-
ity of healthcare [29]. Since the concept of ParkinsonNet
is cost-effective guiding patients to physiotherapists that
are connected to ParkinsonNet, might contribute to the
containment of costs in our health care system. In re-
gions where ParkinsonNet was active, PwP received
more physical therapy, there were fewer admissions to
nursing homes, fewer people needed revalidation treat-
ment, and the reimbursed costs were lower [30]. These
are all reasons for supporting initiatives that enhance
knowledge among PwP about the added value of expert
physiotherapists, by means of CPI that covers a broad
definition of expertise and a range of quality of care
criteria.
Twenty-eight percent of our study population re-
ceived treatment from ParkinsonNet- affiliated physio-
therapists, while 70% claimed treatment from expert
physiotherapists. This percentage of 28 is in line with
previous evidence [18]. Physiotherapists can be expert
in PD without being connected to the multidisciplinary
network, but the chance of being treated by an expert
outside the network is smaller. Moreover, the multidiscip-
linary network has been implemented across the entire
country. It is most likely that respondents overestimate
their physiotherapists’ expertise in PD, otherwise they
would have to admit receiving treatment from a physio-
therapist who might not provide them with the best pos-
sible healthcare. Their overestimation makes switching to
a physiotherapist with PD knowledge unlikely, as in their
view, physiotherapists are already experts in PD. More
consumer knowledge and recognition of expert physio-
therapists might lead to an adjustment of consumers’views towards the level of PD expertise among their
physiotherapists and eventually to a search of CPI.
Implications
Demonstrating the value of expert PD physiotherapists
to referring physicians is necessary. Further research
should explore whether this will encourage selective re-
ferral behaviour. In terms of patient participation, more
attention is required to clarify physicians’ decisions to
refer to an expert physiotherapist.
A practical implication is that CPI should be extended
and made more accessible for PwP and their informal
caregivers (family and friends). For example by spreading
the information through the patient organisations for
PwP on their website or magazine, or flyers in the waiting
room of primary care practices. Further research is needed
to explore how to encourage consumers to use the infor-
mation. The CPI should also emphasise in more detail
how and in what ways expert PD physiotherapists distin-
guish themselves from generic physiotherapists. Both the
added value of expert physiotherapy and the multidiscip-
linary element should be emphasised.
Limitations
This study is not without shortcomings. First, as the un-
derstanding of the added value of an expert physiother-
apist is related to the search for CPI, it would have been
better to have more detailed questions about the percep-
tion of added value. For this purpose, future studies
should focus on the perceived added value of PD expert-
ise in a more extensive way.
Second, we do not know whether the participants’
overestimation of the expertise of their physiotherapist
correlates with their satisfaction with their treatment
and physiotherapist in general. We did not take the
element of consumer satisfaction into account. Future
work should replicate these findings and control for
consumer satisfaction when asking about physiother-
apist expertise in PD. A recent paper shows that consumers
are generally very satisfied with their physiotherapeutic
care [31].
Third, only a minority searched for CPI so that the in-
fluence of the variables could not always be estimated
precisely, which the large confidence intervals reflect.
Fourth, information about the number of physiother-
apy episodes respondents had in the past year would
brought us more insight whether the choice for a physio-
therapist was temporally or more on and on. Future re-
search should use items about the number of episodes,
the length of the episodes and number physiotherapists
they were treated during these episodes.
A strength is that our sample is representative: the mean
age of 72 ± 9 years is in line with the data based on
the Dutch system of diagnosis-treatment combination
Ketelaar et al. BMC Health Services Research 2013, 13:430 Page 8 of 9
http://www.biomedcentral.com/1472-6963/13/430(71 ± 10 years). The gender proportion (56% men)
was also consistent with the national number [32].
According to the Dutch Parkinson guideline, there
are no data available regarding the severity of the
disease.
Conclusions
This study shows that recognition of the added value of
an expert physiotherapist was found to be the strongest
predictor for the search for CPI. The definition of ex-
pertise expressed by PwP was in line with patient-
centeredness, though in a rather narrow manner, as only
certain characteristics of PD expertise were recognised.
In order for PwP choosing high-quality care, improve-
ments are needed. There is a lack of recognition of ex-
pertise caused by a mismatch in the current available
CPI. As PwP showed relatively few signs of selectively
choosing expert physiotherapists, CPI should include
additional and crucial quality of care information that
matters for PwP. After this, it is expected that expert
physiotherapists become more easier recognisable for
those who want to make a selective provider choice. Fur-
thermore, PwP heavily rely on their referring providers,
meaning that referring providers have a responsibility to
act as a coach for their patients. This fact should be used
advantageously by involving the professionals in a more
active way.
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